The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium.
Basic science
COVID-19
Immunology
Impact
Laboratory-based science
Measuring impact
PPI
Patient and public involvement
Public contributors
Journal
Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164
Informations de publication
Date de publication:
22 May 2023
22 May 2023
Historique:
received:
09
09
2022
accepted:
09
05
2023
medline:
23
5
2023
pubmed:
23
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system's response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium. Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers' ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects. The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so.
Sections du résumé
BACKGROUND
BACKGROUND
Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system's response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium.
FINDINGS
RESULTS
Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers' ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects.
CONCLUSION
CONCLUSIONS
The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so.
Identifiants
pubmed: 37217938
doi: 10.1186/s40900-023-00446-1
pii: 10.1186/s40900-023-00446-1
pmc: PMC10201499
doi:
Types de publication
Letter
Langues
eng
Pagination
34Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2019 May 14;14(5):e0216600
pubmed: 31086377
Res Involv Engagem. 2020 Jul 2;6:38
pubmed: 32637153
Res Involv Engagem. 2017 Sep 18;3:20
pubmed: 29062545
Res Involv Engagem. 2021 Jun 14;7(1):41
pubmed: 34127074
F1000Res. 2018 Jun 18;7:752
pubmed: 30364075
Health Expect. 2012 Dec;15(4):389-400
pubmed: 21615638
BMJ. 2018 Dec 6;363:k5147
pubmed: 30522999
Health Expect. 2017 Jun;20(3):484-494
pubmed: 27358109
Res Involv Engagem. 2022 Apr 11;8(1):13
pubmed: 35410450
Health Expect. 2019 Aug;22(4):721-730
pubmed: 30927334
Health Expect. 2017 Jun;20(3):519-528
pubmed: 27338242
Res Involv Engagem. 2021 Mar 8;7(1):13
pubmed: 33685526
Res Involv Engagem. 2019 Mar 12;5:14
pubmed: 30915234
Res Involv Engagem. 2021 May 31;7(1):34
pubmed: 34059159
J Med Eng Technol. 2022 Aug;46(6):472-481
pubmed: 35895020